CHARLES JUDY: Open Payments
NPI 1720085392 · RADFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 58 payments from 22 companies in 2025. Trend: 2023 $1,174 · 2024 $1,285 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $219 |
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| PFIZER INC. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: REXULTI, Ozempic, CAPLYTA, TRELEGY ELLIPTA, TRINTELLIX, Wegovy, NURTEC ODT, Veozah.
Industry payments across VA — which companies pay providers there.
